GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

30 May 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to circular no. CIR/CFD/CMD1/27/2019 dated February 08, 2019, issued by the Securities and Exchange Board of India, for the purpose of compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the Annual Secretarial Compliance Report for the year ended March 31, 2023, issued by Ms. Girija Nagvekar, Practicing Company Secretary and Secretarial Auditor of the Company. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

12 May 2023

70.12

-1.31%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Approval Of Audited Financial Results For …

BSE India

GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023. The Notice can be accessed at the Company''s website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, had been closed from April 01, 2023, will now re-open on Friday, June 02, 2023. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

GKB Ophthalmics Ltd.

19 Apr 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 40 (9) & 40 (10) Of …

BSE India

Pursuant to Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Compliance Certificate, issued by Practicing Company Secretary, for the year ended March 31, 2023. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

14 Apr 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018.

BSE India

Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26, 2018, issued by the Securities and Exchange Board of India , we hereby confirm that GKB Ophthalmics Limited , is not a 'Large Corporate', as defined in the said Circular and hence, the said Circular is not applicable to us. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

07 Apr 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations …

BSE India

Please find herewith the Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, for the year ended March 31, 2023. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

07 Apr 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

03 Apr 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF) , has purchased 40 equity shares aggregating to Rs. 4309.71/- from 27.02.2023 to 01.03.2023 on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta and Sons- HUF. With reference to the disclosure dated March 31, 2023, kindly note that, this is a revised disclosure after correcting the typographical error with respect to the date of purchase of shares which is corrected to 01.03.2023 from 03.01.2023. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Resolutions Passed By The Board Of Directors Of The Company …

BSE India

This is to inform that the Board of Directors of the Company transacted the enclosed matters by resolution passed through Circulation on March 30, 2023. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2023

70.12

-1.31%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF) , has purchased 40 equity shares aggregating to Rs. 4309.71/- from 27.02.2023 to 03.01.2023 on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta and Sons- HUF. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

30 Mar 2023

70.12

-1.31%

SAST

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the 'Trading Window' for dealing/trading in the shares of the Company shall remain closed from April 01, 2023, till the completion of 48 hours after the declaration of the audited financial results of the Company, for the quarter and financial year ended March 31, 2023. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time. Kindly take the information on record.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%